Interestingly, in addition to the potential of KCC2 in treating neurodegenerative diseases, KCC2 hypofunction has also been implicated in age-related memory decline (Ferando et al., 2016; Keramidis et al., 2023; Khademullah et al., 2023). The gene discussed is SLC12A5; the disease is neurodegenerative disease.